Skip to content
Review Open access

RNA-Binding Proteins Regulate CD8+ T Cell Biology: Mechanisms and Therapeutic Opportunities

Oct 2026 · Expert Reviews in Molecular Medicine · Vol 28 · 0 citations · 89 references
Medicine

Abstract

Abstract Background Immune-related diseases contribute substantially to global morbidity and mortality. CD8+ T cells play a critical role in adaptive immunity by eliminating virus-infected and malignant cells. The biology of CD8+ T cells is governed by tightly regulated gene expression programs, and disruption of these programs can lead to diverse immunopathologies and malignancies. This article evaluates our current understanding of post-transcriptional and translational regulation of gene expression in CD8+ T cells by RNA-binding proteins. Methods Relevant and up-to-date literature was critically analysed to gain mechanistic insights into the roles of RNA-binding proteins in CD8+ T cell biology and to identify key knowledge gaps and future directions, with particular emphasis on therapeutic implications. Results RNA-binding proteins regulate diverse aspects of CD8+ T cell biology, including differentiation, cytokine production, stress adaptation and proliferation. Recent studies further reveal how dysregulated expression and function of RNA-binding proteins contribute to hyperinflammation and haematological malignancies. Conclusions RNA-binding proteins are emerging as key post-transcriptional and translational checkpoint regulators of CD8+ T cell biology and represent promising therapeutic targets for immune-related diseases; however, substantial mechanistic and disease-specific studies, as well as rigorous translational validation, are required before RNA-binding protein-targeted therapeutic strategies can be safely and effectively advanced into clinical practice.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.